Skip to main content
Erschienen in: Digestive Diseases and Sciences 8/2018

19.04.2018 | Review

How Should We Report Endoscopic Results in Patient’s with Barrett’s Esophagus?

verfasst von: Venkata Subhash Gorrepati, Prateek Sharma

Erschienen in: Digestive Diseases and Sciences | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Barrett’s esophagus is the only known pre-cancerous lesion for esophageal adenocarcinoma and is diagnosed by high-definition white light endoscopy demonstrating a columnar-lined esophagus along with biopsy evidence of intestinal metaplasia. With accurate performance and reporting of the endoscopic procedure, an evidence-based management strategy can be developed for treatment of Barrett’s dysplasia. However, cross-sectional data demonstrate that there is still inconsistency among gastroenterologists in performance and reporting of endoscopic findings in patients with Barrett’s esophagus. Here, we present an evidence-based review of how to report endoscopic findings in Barrett’s esophagus.
Literatur
2.
Zurück zum Zitat Shaheen NJ, Falk GW, Iyer PG, Gerson LB. ACG clinical guideline: diagnosis and management of Barrett’s esophagus. Am J Gastroenterol. 2016;111:30–50. (quiz 51).CrossRefPubMed Shaheen NJ, Falk GW, Iyer PG, Gerson LB. ACG clinical guideline: diagnosis and management of Barrett’s esophagus. Am J Gastroenterol. 2016;111:30–50. (quiz 51).CrossRefPubMed
3.
Zurück zum Zitat Skinner DB, Walther BC, Riddell RH, Schmidt HE, Lascone C, Demeester TR. Barrett’s esophagus. Comparison of benign and malignant cases. Ann Surg. 1983;198:554–565.CrossRefPubMedPubMedCentral Skinner DB, Walther BC, Riddell RH, Schmidt HE, Lascone C, Demeester TR. Barrett’s esophagus. Comparison of benign and malignant cases. Ann Surg. 1983;198:554–565.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK, et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet. 1994;344:1533–1536.CrossRefPubMed Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK, et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet. 1994;344:1533–1536.CrossRefPubMed
5.
Zurück zum Zitat Jung KW, Talley NJ, Romero Y, et al. Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett’s esophagus: a population-based study. Am J Gastroenterol. 2011;106:1447–1455. (quiz 1456).CrossRefPubMedPubMedCentral Jung KW, Talley NJ, Romero Y, et al. Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett’s esophagus: a population-based study. Am J Gastroenterol. 2011;106:1447–1455. (quiz 1456).CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Sikkema M, Looman CW, Steyerberg EW, et al. Predictors for neoplastic progression in patients with Barrett’s esophagus: a prospective cohort study. Am J Gastroenterol. 2011;106:1231–1238.CrossRefPubMed Sikkema M, Looman CW, Steyerberg EW, et al. Predictors for neoplastic progression in patients with Barrett’s esophagus: a prospective cohort study. Am J Gastroenterol. 2011;106:1231–1238.CrossRefPubMed
7.
Zurück zum Zitat Coleman HG, Bhat SK, Murray LJ, et al. Symptoms and endoscopic features at Barrett’s esophagus diagnosis: implications for neoplastic progression risk. Am J Gastroenterol. 2014;109:527–534.CrossRefPubMed Coleman HG, Bhat SK, Murray LJ, et al. Symptoms and endoscopic features at Barrett’s esophagus diagnosis: implications for neoplastic progression risk. Am J Gastroenterol. 2014;109:527–534.CrossRefPubMed
8.
Zurück zum Zitat Buttar NS, Wang KK, Sebo TJ, et al. Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma. Gastroenterology. 2001;120:1630–1639.CrossRefPubMed Buttar NS, Wang KK, Sebo TJ, et al. Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma. Gastroenterology. 2001;120:1630–1639.CrossRefPubMed
9.
Zurück zum Zitat Montgomery E, Bronner MP, Greenson JK, et al. Are ulcers a marker for invasive carcinoma in Barrett’s esophagus? Data from a diagnostic variability study with clinical follow-up. Am J Gastroenterol. 2002;97:27–31.CrossRefPubMed Montgomery E, Bronner MP, Greenson JK, et al. Are ulcers a marker for invasive carcinoma in Barrett’s esophagus? Data from a diagnostic variability study with clinical follow-up. Am J Gastroenterol. 2002;97:27–31.CrossRefPubMed
10.
Zurück zum Zitat Peters FP, Brakenhoff KP, Curvers WL, et al. Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett’s esophagus. Gastrointest Endosc. 2008;67:604–609.CrossRefPubMed Peters FP, Brakenhoff KP, Curvers WL, et al. Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett’s esophagus. Gastrointest Endosc. 2008;67:604–609.CrossRefPubMed
11.
Zurück zum Zitat Tharavej C, Hagen JA, Peters JH, et al. Predictive factors of coexisting cancer in Barrett’s high-grade dysplasia. Surg Endosc. 2006;20:439–443.CrossRefPubMed Tharavej C, Hagen JA, Peters JH, et al. Predictive factors of coexisting cancer in Barrett’s high-grade dysplasia. Surg Endosc. 2006;20:439–443.CrossRefPubMed
12.
Zurück zum Zitat Sharma N, Srivastava S, Kern F, et al. Endoscopic modalities for the diagnosis of Barrett’s oesophagus. United European Gastroenterol J. 2016;4:733–740.CrossRefPubMed Sharma N, Srivastava S, Kern F, et al. Endoscopic modalities for the diagnosis of Barrett’s oesophagus. United European Gastroenterol J. 2016;4:733–740.CrossRefPubMed
13.
Zurück zum Zitat Brown J, Sharma P. From Prague to Seattle: improved endoscopic technique and reporting improves outcomes in patients with Barrett’s esophagus. Dig Dis Sci. 2016;61:4–5.CrossRefPubMed Brown J, Sharma P. From Prague to Seattle: improved endoscopic technique and reporting improves outcomes in patients with Barrett’s esophagus. Dig Dis Sci. 2016;61:4–5.CrossRefPubMed
14.
Zurück zum Zitat Visrodia K, Iyer PG, Schleck CD, et al. Yield of repeat endoscopy in Barrett’s esophagus with no dysplasia and low-grade dysplasia: a population-based study. Dig Dis Sci. 2016;61:158–167.CrossRefPubMed Visrodia K, Iyer PG, Schleck CD, et al. Yield of repeat endoscopy in Barrett’s esophagus with no dysplasia and low-grade dysplasia: a population-based study. Dig Dis Sci. 2016;61:158–167.CrossRefPubMed
15.
Zurück zum Zitat Singh M, Gupta N, Gaddam S, et al. Practice patterns among U.S. gastroenterologists regarding endoscopic management of Barrett’s esophagus. Gastrointest Endosc. 2013;78:689–695.CrossRefPubMed Singh M, Gupta N, Gaddam S, et al. Practice patterns among U.S. gastroenterologists regarding endoscopic management of Barrett’s esophagus. Gastrointest Endosc. 2013;78:689–695.CrossRefPubMed
16.
Zurück zum Zitat Kwon RS, Adler DG, Chand B, et al. High-resolution and high-magnification endoscopes. Gastrointest Endosc. 2009;69:399–407.CrossRefPubMed Kwon RS, Adler DG, Chand B, et al. High-resolution and high-magnification endoscopes. Gastrointest Endosc. 2009;69:399–407.CrossRefPubMed
17.
Zurück zum Zitat Canto MI, Anandasabapathy S, Brugge W, et al. In vivo endomicroscopy improves detection of Barrett’s esophagus-related neoplasia: a multicenter international randomized controlled trial (with video). Gastrointest Endosc. 2014;79:211–221.CrossRefPubMed Canto MI, Anandasabapathy S, Brugge W, et al. In vivo endomicroscopy improves detection of Barrett’s esophagus-related neoplasia: a multicenter international randomized controlled trial (with video). Gastrointest Endosc. 2014;79:211–221.CrossRefPubMed
18.
Zurück zum Zitat Sharma P, Hawes RH, Bansal A, et al. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett’s oesophagus: a prospective, international, randomised controlled trial. Gut. 2013;62:15–21.CrossRefPubMed Sharma P, Hawes RH, Bansal A, et al. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett’s oesophagus: a prospective, international, randomised controlled trial. Gut. 2013;62:15–21.CrossRefPubMed
19.
Zurück zum Zitat Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63:7–42.CrossRefPubMed Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63:7–42.CrossRefPubMed
20.
Zurück zum Zitat Spechler SJ, Sharma P, Souza RF, et al. American Gastroenterological Association technical review on the management of Barrett’s esophagus. Gastroenterology. 2011;140:e18-52. (quiz e13).CrossRef Spechler SJ, Sharma P, Souza RF, et al. American Gastroenterological Association technical review on the management of Barrett’s esophagus. Gastroenterology. 2011;140:e18-52. (quiz e13).CrossRef
21.
Zurück zum Zitat Boyce HW. Endoscopic definitions of esophagogastric junction regional anatomy. Gastrointest Endosc. 2000;51:586–592.CrossRefPubMed Boyce HW. Endoscopic definitions of esophagogastric junction regional anatomy. Gastrointest Endosc. 2000;51:586–592.CrossRefPubMed
22.
23.
Zurück zum Zitat American Gastroenterological Association. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140:1084–1091.CrossRef American Gastroenterological Association. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140:1084–1091.CrossRef
24.
Zurück zum Zitat Wallner B. Endoscopically defined gastroesophageal junction coincides with the anatomical gastroesophageal junction. Surg Endosc. 2009;23:2155–2158.CrossRefPubMed Wallner B. Endoscopically defined gastroesophageal junction coincides with the anatomical gastroesophageal junction. Surg Endosc. 2009;23:2155–2158.CrossRefPubMed
25.
Zurück zum Zitat Ogiya K, Kawano T, Ito E, et al. Lower esophageal palisade vessels and the definition of Barrett’s esophagus. Dis Esophagus. 2008;21:645–649.CrossRefPubMed Ogiya K, Kawano T, Ito E, et al. Lower esophageal palisade vessels and the definition of Barrett’s esophagus. Dis Esophagus. 2008;21:645–649.CrossRefPubMed
26.
Zurück zum Zitat Andrici J, Tio M, Cox MR, et al. Hiatal hernia and the risk of Barrett’s esophagus. J Gastroenterol Hepatol. 2013;28:415–431.CrossRefPubMed Andrici J, Tio M, Cox MR, et al. Hiatal hernia and the risk of Barrett’s esophagus. J Gastroenterol Hepatol. 2013;28:415–431.CrossRefPubMed
27.
Zurück zum Zitat Johnson DA, Younes Z, Hogan WJ. Endoscopic assessment of hiatal hernia repair. Gastrointest Endosc. 2000;52:650–659.CrossRefPubMed Johnson DA, Younes Z, Hogan WJ. Endoscopic assessment of hiatal hernia repair. Gastrointest Endosc. 2000;52:650–659.CrossRefPubMed
28.
Zurück zum Zitat Kahrilas PJ, Kim HC, Pandolfino JE. Approaches to the diagnosis and grading of hiatal hernia. Best Pract Res Clin Gastroenterol. 2008;22:601–616.CrossRefPubMedPubMedCentral Kahrilas PJ, Kim HC, Pandolfino JE. Approaches to the diagnosis and grading of hiatal hernia. Best Pract Res Clin Gastroenterol. 2008;22:601–616.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Weusten B, Bisschops R, Coron E, et al. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy. 2017;49:191–198.CrossRefPubMed Weusten B, Bisschops R, Coron E, et al. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy. 2017;49:191–198.CrossRefPubMed
30.
Zurück zum Zitat Gopal DV, Lieberman DA, Magaret N, et al. Risk factors for dysplasia in patients with Barrett’s esophagus (BE): results from a multicenter consortium. Dig Dis Sci. 2003;48:1537–1541.CrossRefPubMed Gopal DV, Lieberman DA, Magaret N, et al. Risk factors for dysplasia in patients with Barrett’s esophagus (BE): results from a multicenter consortium. Dig Dis Sci. 2003;48:1537–1541.CrossRefPubMed
31.
Zurück zum Zitat Menke-Pluymers MB, Hop WC, Dees J, et al. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer. 1993;72:1155–1158.CrossRefPubMed Menke-Pluymers MB, Hop WC, Dees J, et al. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer. 1993;72:1155–1158.CrossRefPubMed
32.
Zurück zum Zitat Anaparthy R, Gaddam S, Kanakadandi V, et al. Association between length of Barrett’s esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia. Clin Gastroenterol Hepatol. 2013;11:1430–1436.CrossRefPubMed Anaparthy R, Gaddam S, Kanakadandi V, et al. Association between length of Barrett’s esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia. Clin Gastroenterol Hepatol. 2013;11:1430–1436.CrossRefPubMed
33.
Zurück zum Zitat Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE. Dysplasia in short-segment Barrett’s esophagus: a prospective 3-year follow-up. Am J Gastroenterol. 1997;92:2012–2016.PubMed Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE. Dysplasia in short-segment Barrett’s esophagus: a prospective 3-year follow-up. Am J Gastroenterol. 1997;92:2012–2016.PubMed
34.
Zurück zum Zitat Weston AP, Krmpotich PT, Cherian R, Dixon A, Topalosvki M. Prospective long-term endoscopic and histological follow-up of short segment Barrett’s esophagus: comparison with traditional long segment Barrett’s esophagus. Am J Gastroenterol. 1997;92:407–413.PubMed Weston AP, Krmpotich PT, Cherian R, Dixon A, Topalosvki M. Prospective long-term endoscopic and histological follow-up of short segment Barrett’s esophagus: comparison with traditional long segment Barrett’s esophagus. Am J Gastroenterol. 1997;92:407–413.PubMed
35.
Zurück zum Zitat Conio M, Aste H, Bonelli L. “Short” Barrett’s esophagus: a condition not to be underestimated. Gastrointest Endosc. 1994;40:111.CrossRefPubMed Conio M, Aste H, Bonelli L. “Short” Barrett’s esophagus: a condition not to be underestimated. Gastrointest Endosc. 1994;40:111.CrossRefPubMed
36.
Zurück zum Zitat Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131:1392–1399.CrossRefPubMed Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131:1392–1399.CrossRefPubMed
37.
Zurück zum Zitat Alvarez Herrero L, Curvers WL, Van Vilsteren FG, et al. Validation of the Prague C&M classification of Barrett’s esophagus in clinical practice. Endoscopy. 2013;45:876–882.CrossRefPubMed Alvarez Herrero L, Curvers WL, Van Vilsteren FG, et al. Validation of the Prague C&M classification of Barrett’s esophagus in clinical practice. Endoscopy. 2013;45:876–882.CrossRefPubMed
38.
Zurück zum Zitat Vahabzadeh B, Seetharam AB, Cook MB, et al. Validation of the Prague C & M criteria for the endoscopic grading of Barrett’s esophagus by gastroenterology trainees: a multicenter study. Gastrointest Endosc. 2012;75:236–241.CrossRefPubMedPubMedCentral Vahabzadeh B, Seetharam AB, Cook MB, et al. Validation of the Prague C & M criteria for the endoscopic grading of Barrett’s esophagus by gastroenterology trainees: a multicenter study. Gastrointest Endosc. 2012;75:236–241.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Chang CY, Lee YC, Lee CT, et al. The application of Prague C and M criteria in the diagnosis of Barrett’s esophagus in an ethnic Chinese population. Am J Gastroenterol. 2009;104:13–20.CrossRefPubMed Chang CY, Lee YC, Lee CT, et al. The application of Prague C and M criteria in the diagnosis of Barrett’s esophagus in an ethnic Chinese population. Am J Gastroenterol. 2009;104:13–20.CrossRefPubMed
40.
Zurück zum Zitat Lee YC, Cook MB, Bhatia S, et al. Interobserver reliability in the endoscopic diagnosis and grading of Barrett’s esophagus: an Asian multi-national study. Endoscopy. 2010;42:699–704.CrossRefPubMedPubMedCentral Lee YC, Cook MB, Bhatia S, et al. Interobserver reliability in the endoscopic diagnosis and grading of Barrett’s esophagus: an Asian multi-national study. Endoscopy. 2010;42:699–704.CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Gupta N, Gaddam S, Wani SB, et al. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus. Gastrointest Endosc. 2012;76:531–538.CrossRefPubMed Gupta N, Gaddam S, Wani SB, et al. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus. Gastrointest Endosc. 2012;76:531–538.CrossRefPubMed
42.
Zurück zum Zitat Bisschops R, Areia M, Coron E, et al. Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy quality improvement initiative. United European Gastroenterol J. 2016;4:629–656.CrossRefPubMedPubMedCentral Bisschops R, Areia M, Coron E, et al. Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy quality improvement initiative. United European Gastroenterol J. 2016;4:629–656.CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Enestvedt BK, Lugo R, Guarner-Argente C, et al. Location, location, location: does early cancer in Barrett’s esophagus have a preference? Gastrointest Endosc. 2013;78:462–467.CrossRefPubMed Enestvedt BK, Lugo R, Guarner-Argente C, et al. Location, location, location: does early cancer in Barrett’s esophagus have a preference? Gastrointest Endosc. 2013;78:462–467.CrossRefPubMed
44.
Zurück zum Zitat Kariyawasam VC, Bourke MJ, Hourigan LF, et al. Circumferential location predicts the risk of high-grade dysplasia and early adenocarcinoma in short-segment Barrett’s esophagus. Gastrointest Endosc. 2012;75:938–944.CrossRefPubMed Kariyawasam VC, Bourke MJ, Hourigan LF, et al. Circumferential location predicts the risk of high-grade dysplasia and early adenocarcinoma in short-segment Barrett’s esophagus. Gastrointest Endosc. 2012;75:938–944.CrossRefPubMed
45.
Zurück zum Zitat Cassani L, Sumner E, Slaughter JC, et al. Directional distribution of neoplasia in Barrett’s esophagus is not influenced by distance from the gastroesophageal junction. Gastrointest Endosc. 2013;77:877–882.CrossRefPubMed Cassani L, Sumner E, Slaughter JC, et al. Directional distribution of neoplasia in Barrett’s esophagus is not influenced by distance from the gastroesophageal junction. Gastrointest Endosc. 2013;77:877–882.CrossRefPubMed
46.
Zurück zum Zitat Axon A, Diebold MD, Fujino M, et al. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy. 2005;37:570–578.CrossRef Axon A, Diebold MD, Fujino M, et al. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy. 2005;37:570–578.CrossRef
47.
Zurück zum Zitat Prasad GA, Bansal A, Sharma P, et al. Predictors of progression in Barrett’s esophagus: current knowledge and future directions. Am J Gastroenterol. 2010;105:1490–1502.CrossRefPubMedPubMedCentral Prasad GA, Bansal A, Sharma P, et al. Predictors of progression in Barrett’s esophagus: current knowledge and future directions. Am J Gastroenterol. 2010;105:1490–1502.CrossRefPubMedPubMedCentral
48.
Zurück zum Zitat Pech O, Gossner L, Manner H, et al. Prospective evaluation of the macroscopic types and location of early Barrett’s neoplasia in 380 lesions. Endoscopy. 2007;39:588–593.CrossRefPubMed Pech O, Gossner L, Manner H, et al. Prospective evaluation of the macroscopic types and location of early Barrett’s neoplasia in 380 lesions. Endoscopy. 2007;39:588–593.CrossRefPubMed
49.
Zurück zum Zitat Abela JE, Going JJ, Mackenzie JF, et al. Systematic four-quadrant biopsy detects Barrett’s dysplasia in more patients than nonsystematic biopsy. Am J Gastroenterol. 2008;103:850–855.CrossRefPubMed Abela JE, Going JJ, Mackenzie JF, et al. Systematic four-quadrant biopsy detects Barrett’s dysplasia in more patients than nonsystematic biopsy. Am J Gastroenterol. 2008;103:850–855.CrossRefPubMed
50.
Zurück zum Zitat Levine DS, Blount PL, Rudolph RE, et al. Safety of a systematic endoscopic biopsy protocol in patients with Barrett’s esophagus. Am J Gastroenterol. 2000;95:1152–1157.CrossRefPubMed Levine DS, Blount PL, Rudolph RE, et al. Safety of a systematic endoscopic biopsy protocol in patients with Barrett’s esophagus. Am J Gastroenterol. 2000;95:1152–1157.CrossRefPubMed
51.
Zurück zum Zitat Boerwinkel DF, Swager AF, Curvers WL, Bergman JJ. The clinical consequences of advanced imaging techniques in Barrett’s esophagus. Gastroenterology. 2014;146:622–629.CrossRefPubMed Boerwinkel DF, Swager AF, Curvers WL, Bergman JJ. The clinical consequences of advanced imaging techniques in Barrett’s esophagus. Gastroenterology. 2014;146:622–629.CrossRefPubMed
52.
Zurück zum Zitat Gill RS, Singh R. Endoscopic imaging in Barrett’s esophagus: current practice and future applications. Ann Gastroenterol. 2012;25:89–95.PubMedPubMedCentral Gill RS, Singh R. Endoscopic imaging in Barrett’s esophagus: current practice and future applications. Ann Gastroenterol. 2012;25:89–95.PubMedPubMedCentral
53.
Zurück zum Zitat Wolfsen HC, Sharma P, Wallace MB, et al. Safety and feasibility of volumetric laser endomicroscopy in patients with Barrett’s esophagus (with videos). Gastrointest Endosc. 2015;82:631–640.CrossRefPubMed Wolfsen HC, Sharma P, Wallace MB, et al. Safety and feasibility of volumetric laser endomicroscopy in patients with Barrett’s esophagus (with videos). Gastrointest Endosc. 2015;82:631–640.CrossRefPubMed
54.
Zurück zum Zitat ASGE Technology Committee, Dayyeh BK, Thosani N, et al. ASGE Technology Committee systematic review and meta-analysis assessing the ASGE Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for adopting real-time imaging-assisted endoscopic targeted biopsy during endoscopic surveillance of Barrett’s esophagus. Gastrointest Endosc. 2016;83:684–698.CrossRef ASGE Technology Committee, Dayyeh BK, Thosani N, et al. ASGE Technology Committee systematic review and meta-analysis assessing the ASGE Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for adopting real-time imaging-assisted endoscopic targeted biopsy during endoscopic surveillance of Barrett’s esophagus. Gastrointest Endosc. 2016;83:684–698.CrossRef
55.
Zurück zum Zitat Sharma P, Brill J, Canto M, et al. White paper AGA: advanced imaging in Barrett’s esophagus. Clin Gastroenterol Hepatol. 2015;13:2209–2218.CrossRefPubMed Sharma P, Brill J, Canto M, et al. White paper AGA: advanced imaging in Barrett’s esophagus. Clin Gastroenterol Hepatol. 2015;13:2209–2218.CrossRefPubMed
56.
Zurück zum Zitat Chedgy FJQ, Subramaniam S, Kandiah K, et al. Acetic acid chromoendoscopy: improving neoplasia detection in Barrett’s esophagus. World J Gastroenterol. 2016;22:5753–5760.CrossRefPubMedPubMedCentral Chedgy FJQ, Subramaniam S, Kandiah K, et al. Acetic acid chromoendoscopy: improving neoplasia detection in Barrett’s esophagus. World J Gastroenterol. 2016;22:5753–5760.CrossRefPubMedPubMedCentral
57.
Zurück zum Zitat Reaud S, Croue A, Boyer J. Diagnostic accuracy of magnifying chromoendoscopy with detection of intestinal metaplasia and dysplasia using acetic acid in Barrett’s esophagus. Gastroenterol Clin Biol. 2006;30:217–223.CrossRefPubMed Reaud S, Croue A, Boyer J. Diagnostic accuracy of magnifying chromoendoscopy with detection of intestinal metaplasia and dysplasia using acetic acid in Barrett’s esophagus. Gastroenterol Clin Biol. 2006;30:217–223.CrossRefPubMed
58.
Zurück zum Zitat Mayinger B, Oezturk Y, Stolte M, et al. Evaluation of sensitivity and inter- and intra-observer variability in the detection of intestinal metaplasia and dysplasia in Barrett’s esophagus with enhanced magnification endoscopy. Scand J Gastroenterol. 2006;41:349–356.CrossRefPubMed Mayinger B, Oezturk Y, Stolte M, et al. Evaluation of sensitivity and inter- and intra-observer variability in the detection of intestinal metaplasia and dysplasia in Barrett’s esophagus with enhanced magnification endoscopy. Scand J Gastroenterol. 2006;41:349–356.CrossRefPubMed
59.
Zurück zum Zitat Yagi K, Nakamura A, Sekine A, et al. Endoscopic diagnosis of mucosal adenocarcinomas and intestinal metaplasia of columnar-lined esophagus using enhanced-magnification endoscopy. Dig Endosc. 2006;18:S21–S26.CrossRef Yagi K, Nakamura A, Sekine A, et al. Endoscopic diagnosis of mucosal adenocarcinomas and intestinal metaplasia of columnar-lined esophagus using enhanced-magnification endoscopy. Dig Endosc. 2006;18:S21–S26.CrossRef
60.
Zurück zum Zitat Fortun PJ, Anagnostopoulos GK, Kaye P, et al. Acetic acid-enhanced magnification endoscopy in the diagnosis of specialized intestinal metaplasia, dysplasia and early cancer in Barrett’s oesophagus. Aliment Pharmacol Ther. 2006;23:735–742.CrossRefPubMed Fortun PJ, Anagnostopoulos GK, Kaye P, et al. Acetic acid-enhanced magnification endoscopy in the diagnosis of specialized intestinal metaplasia, dysplasia and early cancer in Barrett’s oesophagus. Aliment Pharmacol Ther. 2006;23:735–742.CrossRefPubMed
61.
Zurück zum Zitat Bhandari P, Kandaswamy P, Cowlishaw D, et al. Acetic acid-enhanced chromoendoscopy is more cost-effective than protocol-guided biopsies in a high-risk Barrett’s population. Dis Esophagus. 2012;25:386–392.CrossRefPubMed Bhandari P, Kandaswamy P, Cowlishaw D, et al. Acetic acid-enhanced chromoendoscopy is more cost-effective than protocol-guided biopsies in a high-risk Barrett’s population. Dis Esophagus. 2012;25:386–392.CrossRefPubMed
62.
Zurück zum Zitat Longcroft–Wheaton G, Duku M, Mead R, et al. Acetic acid spray is an effective tool for the endoscopic detection of neoplasia in patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2010;8:843–847.CrossRefPubMed Longcroft–Wheaton G, Duku M, Mead R, et al. Acetic acid spray is an effective tool for the endoscopic detection of neoplasia in patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2010;8:843–847.CrossRefPubMed
63.
Zurück zum Zitat Pohl J, May A, Rabenstein T, et al. Comparison of computed virtual chromoendoscopy and conventional chromoendoscopy with acetic acid for detection of neoplasia in Barrett’s esophagus. Endoscopy. 2007;39:594–598.CrossRefPubMed Pohl J, May A, Rabenstein T, et al. Comparison of computed virtual chromoendoscopy and conventional chromoendoscopy with acetic acid for detection of neoplasia in Barrett’s esophagus. Endoscopy. 2007;39:594–598.CrossRefPubMed
64.
Zurück zum Zitat Vazquez-Iglesias JL, Alonso-Aguirre P, Diz-Lois MT, et al. Acetic acid allows effective selection of areas for obtaining biopsy samples in Barrett’s esophagus. Eur J Gastroenterol Hepatol. 2007;19:187–193.CrossRefPubMed Vazquez-Iglesias JL, Alonso-Aguirre P, Diz-Lois MT, et al. Acetic acid allows effective selection of areas for obtaining biopsy samples in Barrett’s esophagus. Eur J Gastroenterol Hepatol. 2007;19:187–193.CrossRefPubMed
65.
Zurück zum Zitat Pohl J, Pech O, May A, et al. Incidence of macroscopically occult neoplasias in Barrett’s esophagus: are random biopsies dispensable in the era of advanced endoscopic imaging? Am J Gastroenterol. 2010;105:2350–2356.CrossRefPubMed Pohl J, Pech O, May A, et al. Incidence of macroscopically occult neoplasias in Barrett’s esophagus: are random biopsies dispensable in the era of advanced endoscopic imaging? Am J Gastroenterol. 2010;105:2350–2356.CrossRefPubMed
66.
Zurück zum Zitat Coletta M, Sami SS, Nachiappan A, Fraquelli M, Casazza G, Ragunath K. Acetic acid chromoendoscopy for the diagnosis of early neoplasia and specialized intestinal metaplasia in Barrett’s esophagus: a meta-analysis. Gastrointest Endosc. 2016;83:57–67.CrossRefPubMed Coletta M, Sami SS, Nachiappan A, Fraquelli M, Casazza G, Ragunath K. Acetic acid chromoendoscopy for the diagnosis of early neoplasia and specialized intestinal metaplasia in Barrett’s esophagus: a meta-analysis. Gastrointest Endosc. 2016;83:57–67.CrossRefPubMed
68.
Zurück zum Zitat Wani S, Sharma P. Narrow band imaging in Barrett’s esophagus. Expert Rev Gastroenterol Hepatol. 2007;1:53–60.CrossRefPubMed Wani S, Sharma P. Narrow band imaging in Barrett’s esophagus. Expert Rev Gastroenterol Hepatol. 2007;1:53–60.CrossRefPubMed
69.
Zurück zum Zitat Wolfsen HC, Crook JE, Krishna M, et al. Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett’s Esophagus. Gastroenterology. 2008;135:24–31.CrossRefPubMed Wolfsen HC, Crook JE, Krishna M, et al. Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett’s Esophagus. Gastroenterology. 2008;135:24–31.CrossRefPubMed
70.
Zurück zum Zitat Sharma P, Bergman JJ, Goda K, et al. Development and validation of a classification system to identify high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus using narrow-band imaging. Gastroenterology. 2016;150:591–598.CrossRefPubMed Sharma P, Bergman JJ, Goda K, et al. Development and validation of a classification system to identify high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus using narrow-band imaging. Gastroenterology. 2016;150:591–598.CrossRefPubMed
Metadaten
Titel
How Should We Report Endoscopic Results in Patient’s with Barrett’s Esophagus?
verfasst von
Venkata Subhash Gorrepati
Prateek Sharma
Publikationsdatum
19.04.2018
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 8/2018
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5067-7

Weitere Artikel der Ausgabe 8/2018

Digestive Diseases and Sciences 8/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.